BRAIN, READING AND WRITING

Whatever the alphabet we use or the culture in which we are raised, it’s always the same small region of the visual cortex in the left hemisphere that allows us to identify the letters we see. Why, then, in the …

TOWARDS A MORE TARGETED THERAPY FOR BRAIN TUMOURS

Today, in France, about 5000 new carriers of malignant primary brain tumours are diagnosed each year. The symptoms depend on the localization of the tumour, its size and the rate at which it

THE ICM CO-RECIPIENT OF THE NIH “BRAIN” INITIATIVE GRANT

The team of Dr. Claire Wyart at the Brain and Spine Institute – ICM (UPMC, INSERM, CNRS,

CONFABULATORS: WHEN MEMORY PLAYS TRICKS

“What did you do yesterday?” “I went to work,” the subjects answers,

WHEN BREATHING FREES OUR MIND

Comparison of the cerebral and cognitive resources solicited during automatic or voluntary

PROGRESS IN ALZHEIMER’S THROUGH CEREBRAL CONNECTIVITY

The research collaboration between Professor Harald Hampel (AXA Research Fund and UPMC Chair

COMPLEX NETWORK THEORY AND THE BRAIN

Two researchers of the Institut du Cerveau et de la Moelle épinière – ICM – Brain and

A NEW TARGET FOR THE TREATMENT OF SCHIZOPHRENIA

The Biotechnology & Biotherapy team, created by Dr. Jacques Mallet and presently directed

ICM ANNUAL REPORT 2013

In the annual report, you will find all 2013 key facts, a presentation of pathologies, the

ALZHEIMER DISEASE, RESEARCH IS ADVANCING AT THE ICM

Alzheimer disease is a major source of preoccupation. A real issue for public health at a

PARKINSON’S DISEASE: DISCOVERY OF 6 NEW GENETIC RISK FACTORS

6 genetic risk factors for Parkinson’s disease have been discovered thanks to a study

NEUROETHICS CONSORTIUM AT THE ICM

Neuroscience, Ethics and Society (NES) is an initiative of ICM, for the purpose of integrating

EXTRA-SCIENTIFIC CONFERENCE WITH PROFESSOR JOHN HARRIS

On Thursday, June 19th, the ICM Brain and Spine Institute hosted an extra-scientific

A NEW STRATEGIC WAY OF PROCESSING VISUAL INFORMATION OF THE BRAIN

A recent study made by Lionel Naccache, researcher at the ICM and neurologist at

LIVE IN HALF THE WORLD

Paolo Bartolomeo, Doctor and neurosciences researcher just published a book, entitled

NEW THERAPEUTIC TARGETS IN MS

A team of the ICM just highlighted interactions between genes potentially involved in multiple

MOTORNEURONE DISEASES : 18 NEW CAUSATIVE GENES !

A research team of the ICM institute took part to an international study identifying 18 new

CREUTZFELDT-JAKOB DISEASE : NEW PERSPECTIVES

An international clinical trial in Creutzfeldt-Jakob disease was conducted in France and

THE ENDOPLASMIC RETICULUM IMPLICATED IN MOTONEURONS DISEASES

Researchers of the ICM institute just discovered a new causative gene implicated in hereditary

NEW EARLY MARKER IN PARKINSON’S DISEASE

A paper published in the prestigious journal Brain by a team of the ICM institute link rapid

CONGENITAL MIRROR MOVEMENTS: A NOVEL CLUE TO UNDERSTANDING BIMANUAL MOTOR CONTROL

The illustration of this article is on the cover of the latest issue of the journal

NEURODEGENERATIVE DISEASES : A NEW GENE

Isabelle Le Ber, in Pr Alexis Brice’s team from the Brain and Spine Institute, highlighted

A NEW CEREBRAL MEASURE OF CONSCIOUSNESS

Every year, thousands of people fall into a coma leading to a vegetative or a minimally

THE ENZYME PDK1 PROMOTES DISEASE PROGRESSION IN PRION AND ALZHEIMER’S DISEASES

    A researcher team (Inserm747, Paris-Descartes) with Stephane Haïk (Inserm UMR

POTENTIAL ROLE OF MUSCLE HDAC4 IN SLA PROGRESSION

Amyotrophic lateral sclerosis is a typically rapidly progressive neurodegenerative disorder

CALL FOR APPLICATION IHU-A-ICM

 The IHU-A-ICM launches a new call for application. The ICM was one of the six candidates

HEREDITARY SPASTIC PARAPLEGIA : AN IMPROVEMENT

Hereditary Spastic Paraplegia (HSP) are a genetically heterogeneous group of invalidating

LEUCODYSTROPHY: A NEW FORM ASSOCIATED WITH CLC-2 CHLORIDE CHANNEL

Brain white matter oedema due ClC-2 chloride channel defiency. Brain white matter oedema are

IMPROVEMENT: TYPE 7 SPINOCEREBELLAR ATAXIA

The interferon beta: a therapeutic strategy for the type 7 spinocerebellar ataxia The aim of

ALS: GENETIC DISCOVERY

ALS and FTLD are prevalent neurodegenerative disorders which share common clinical,

BB CYCLE TOUR FOR THE ICM WITH FERBLANC FUNDRAISING

      Henry Raker came to the ICM today and gave to Pr Gérard Saillant the cheque of

INNOBIO AND SOFINNOVA PARTNERS INVEST BIOTECH MEDDAY

15 avril 2013       MedDay is a French biotech company in the treatment of